Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Gilead Sciences Inc. (GILD) stock fell 1.31% to $125.84 on Friday, underperforming compared to competitors. The S&P 500 Index rose 0.54% and the Dow Jones Industrial Average rose 0.61%. Gilead's stock ended a two-day winning streak and closed 2.22% below its 52-week high. Trading volume was 3.1 million, below the 50-day average of 7.6 million.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 1.31% to $125.84 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.54% to 6,849.09 and the Dow Jones Industrial Average rising 0.61% to 47,716.42.
The stock's fall snapped a two-day winning streak.
Gilead Sciences Inc. closed 2.22% below its 52-week high of $128.70, which the company reached on November 20th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.31% to $206.92, Pfizer Inc. (PFE) rose 0.12% to $25.74, and Abbott Laboratories (ABT) rose 0.28% to $128.90.
Trading volume (3.1 M) remained 4.5 million below its 50-day average volume of 7.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-28-25 1635ET